A platform for SpyCatcher conjugation to native antibodies

Sona Krajcovicova, Thomas Wharton, Claudia L. Driscoll, Thomas A. King, Mark R. Howarth and David R. Spring

Chem. Sci., 2025, 16, 10602
DOI: 10.1039/D5SC02286J

Fluorine-18 and Radiometal Labeling of Biomolecules via Disulfide Rebridging

Mylène Richard, Soizic Martin Aubert, Caroline Denis, Steven Dubois, Hervé Nozach, Charles Truillet and Bertrand Kuhnast

Bioconjugate Chem., 2023, 34, 2123
DOI: 10.1021/acs.bioconjchem.3c00440

Peptide and Protein Cysteine Modification Enabled by Hydrosulfuration of Ynamide

Changliu Wang, Zhenguang Zhao, Reem Ghadir, Dechun Yang, Zhenjia Zhang, Zhe Ding, Yuan Cao, Yuqing Li, Rosi Fassler, Dana Reichmann, Yujie Zhang, Yongli Zhao, Can Liu, Xiaobao Bi, Norman Metanis and Junfeng Zhao

ACS Cent. Sci., 2024, 10, 1742
DOI: 10.1021/acscentsci.4c01148

Precision engineering of antibodies: A review of modification and design in the Fab region

Sa Wang, Yao Li, Jianfeng Mei, Shujiang Wu, Guoqing Ying and Yu Yi

International Journal of Biological Macromolecules, 2024, 275, 133730
DOI: 10.1016/j.ijbiomac.2024.133730

Unlocking Amides: A General Method for the Self‐Immolative Release of Amide‐Containing Molecules

Thomas Wharton, Felicity Crawshay‐Williams, Tim Schober, R. Andres Floto and David R. Spring

Angewandte Chemie, 2024, 136
DOI: 10.1002/ange.202402267

Methods for the Generation of Single‐Payload Antibody‐Drug Conjugates

Thomas Wharton and David R. Spring

ChemMedChem, 2025, 20
DOI: 10.1002/cmdc.202500132

Ungesättigte Phosphinoxide für modulares Antikörper‐Rebridging und Einkomponenten Peptid‐Zyklisierung‐Biokonjugation

Christian E. Stieger, Alastair J. McMillan, Mark A. R. de Geus, Jan Vincent V. Arafiles, Luise Franz and Christian P. R. Hackenberger

Angewandte Chemie, 2025, 137
DOI: 10.1002/ange.202508656

The Evolution of Antibody‐Drug Conjugates: Toward Accurate DAR and Multi‐specificity

Wenge Dong, Wanqi Wang and Chan Cao

ChemMedChem, 2024, 19
DOI: 10.1002/cmdc.202400109

Unsaturated Phosphine Oxides for Modular Antibody Rebridging and Single Reagent Peptide‐Cyclization‐Bioconjugation

Christian E. Stieger, Alastair J. McMillan, Mark A. R. de Geus, Jan Vincent V. Arafiles, Luise Franz and Christian P. R. Hackenberger

Angew Chem Int Ed, 2025, 64
DOI: 10.1002/anie.202508656

Facile Rebridging Conjugation Approach to Attain Monoclonal Antibody-Targeted Nanoparticles with Enhanced Antigen Binding and Payload Delivery

Bayan Alkhawaja, Duaa Abuarqoub, Mohammad Al-natour, Walhan Alshaer, Qasem Abdallah, Ezaldeen Esawi, Malak Jaber, Nour Alkhawaja, Bayan Y. Ghanim, Nidal Qinna and Andrew G. Watts

Bioconjugate Chem., 2024
DOI: 10.1021/acs.bioconjchem.4c00275

Theranostic antibody conjugates: A review of recent trends and applications in cancer

Keyvan Kheyrolahzadeh, Maryam Mojahedi, Mohammad Reza Tohidkia and Ayuob Aghanejad

Bioorganic Chemistry, 2025, 164, 108915
DOI: 10.1016/j.bioorg.2025.108915

Understanding the chemistry & pharmacology of antibody–drug conjugates in triple-negative breast cancer with special reference to exatecan derivatives

Sanjana Sawant, Gaurav Gopal Naik, Alakh N. Sahu and Vijay A. Jagtap

Med Oncol, 2024, 41
DOI: 10.1007/s12032-024-02542-y

Therapeutic potential of antibody-drug conjugates possessing bifunctional anti-inflammatory action in the pathogenesis of rheumatoid arthritis

Tanu Dixit, Anuradha Vaidya and Selvan Ravindran

Arthritis Res Ther, 2024, 26
DOI: 10.1186/s13075-024-03452-0

Unlocking Amides: A General Method for the Self‐Immolative Release of Amide‐Containing Molecules

Thomas Wharton, Felicity Crawshay‐Williams, Tim Schober, R. Andres Floto and David R. Spring

Angew Chem Int Ed, 2024, 63
DOI: 10.1002/anie.202402267